ULK1 and metabolic dysfunction-associated steatohepatitis: An autophagic flux analysis using CQ showed that the expression of LC3II in the gemigliptin-treated group was comparable to that in the NASH model group after knockdown of ULK1, indicating that gemigliptin can induce autophagy in the absence of ULK1 expression (Figure 6B).